Presence of mEGFR ctDNA predicts a poor clinical outcome in lung adenocarcinoma.
Tae Hee KimEun Young KimSang Hoon LeeDo Sun KwonArum KimYoon Soo ChangPublished in: Thoracic cancer (2019)
These data showed that mEGFR ctDNA detection using ddPCR is useful in the advanced stages and its presence predicted distant metastasis and poor clinical outcome in lung adenocarcinoma.